Study Results for Zargis' Cardioscan to be Presented at American Academy of Pediatrics Conference

Study Co-Author Dr. Reid Thompson of Johns Hopkins University's School of Medicine to Present a Summary of the Findings 


PRINCETON, N.J., Sept. 13  /PRNewswire/ -- Zargis Medical Corp., a spin-off from Siemens Corporate Research (NYSE:SI) and a majority-owned subsidiary of Speedus Corp. (NASDAQ:SPDE), today announced that a summary of the results of the previously announced physician study conducted in 2005 will be presented at the 2006 American Academy of Pediatrics (AAP) National Conference & Exhibition. The study, entitled "The Impact of Computer-Assisted Auscultation on Physician Recognition and Interpretation of Heart Murmurs", assessed the impact of Zargis' Cardioscan(R) device on referral decisions made by primary care physicians regarding heart murmurs-which are potential indicators of heart disease.

The complete study results have been submitted to a peer-reviewed medical journal for publication, and a summary of the results will be made available following the AAP presentation.

The AAP is an organization of 60,000 pediatricians committed to the attainment of optimal physical, mental, and social health and well-being for all infants, children, adolescents, and young adults. The 2006 AAP National Conference & Exhibition takes place October 7-10 in Atlanta. The event serves as a forum at which pediatric professionals from around the world come together for updates and reviews of pediatric practice, research, and advocacy.

About Zargis Medical Corp.

Zargis Medical Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE:SI), and Speedus Corp. co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds.

About Cardioscan

Zargis has developed Cardioscan, the first and only computer-assisted medical device designed to support physicians in analyzing heart sounds for the identification of suspected systolic and diastolic murmurs. Cardioscan is a non-invasive device that is easy to use, portable, and takes just minutes to perform. The device implements voice-guided protocol and a graphical user interface while maintaining an efficient physician workflow. Cardioscan provides a summary of findings in terms that are readily understood by physicians and offers an additional range of quantitative auscultatory information that cannot be obtained through listening alone. As a result, Cardioscan enhances auscultation-a procedure that has been universally employed through a stethoscope for nearly two-hundred years.

For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or  or visit the following Web sites: http://www.zargis.com/ and http://www.speedus.com/.

Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward- looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts. 

DATASOURCE: Zargis Medical



CONTACT:  Peter Hodge of Zargis Medical, 1-888-773-3669 ext. 23,





Web site:  http://www.speedus.com/

http://www.zargis.com/ 

Copyright